| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kairos Pharma, LTD. | CEO and Chairman, Director, 10%+ Owner | COMMON STOCK | 5,316,572 | $5,848,229 | $1.10 | 08 Oct 2025 | By Self as Trustee for The Yu Family Trust |
| Kairos Pharma, LTD. | CEO and Chairman, Director, 10%+ Owner | COMMON STOCK | 230,105 | $253,115 | $1.10 | 08 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KAPA | Kairos Pharma, LTD. | 08 Oct 2025 | 1 | $0 | 4 | CEO and Chairman, Director, 10%+ Owner | 26 Nov 2025, 17:24 |
| KAPA | Kairos Pharma, LTD. | 01 Jan 2025 | 1 | $0 | 4 | CEO and Chairman, Director, 10%+ Owner | 24 Feb 2025, 18:51 |
| KAPA | Kairos Pharma, LTD. | 20 Nov 2024 | 1 | +$5,760 | 4 | CEO and Chairman, Director, 10%+ Owner | 21 Nov 2024, 21:53 |
| KAPA | Kairos Pharma, LTD. | 16 Sep 2024 | 0 | $0 | 3 | CEO and Chairman, Director, 10%+ Owner | 24 Sep 2024, 21:00 |